Equity Overview
Price & Market Data
Price: $0.0073
Daily Change: +$0.0₃22 / 3.01%
Daily Range: $0.00675 - $0.0073
Market Cap: $7,831,173
Daily Volume: 11,000
Performance Metrics
1 Week: 12.31%
1 Month: 25.00%
3 Months: 6.18%
6 Months: -22.75%
1 Year: -48.41%
YTD: 47.47%
Details
Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.